NCT00167154View on ClinicalTrials.gov

Risperidone and Suicidality in Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

August 31, 2008

Conditions

Depression

Interventions

DRUG

Risperidone and placebo comparator

Up to 2 mg risperidone or matching placebo daily

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

Sponsors

Collaborators (1)

Janssen Pharmaceuticals

All Listed Sponsors

collaborator

Janssen Pharmaceuticals

INDUSTRY

lead

University of Alabama at Birmingham

OTHER

NCT00167154 - Risperidone and Suicidality in Major Depressive Disorder | Biotech Hunter | Biotech Hunter